Filya Zhebrovska has spent the last three decades working in Ukraine’s pharmaceutical market at Farmak, the country’s leading drug producer, which she now heads.
Under her leadership, Farmak today makes over 10 percent of the drugs produced in Ukraine, including more than 200 drugs in various categories.
The company in 2009 returned to growth, compared to a drop in sales a year earlier. Over the first six months of 2010, Farmak further improved retail sales, earning $19 million in net profits.
The Zhytomyr Oblast native started working for Farmak in 1980 as an accountant, moving up the executive ladder in the early 1990s to deputy director.
She was named Farmak director in 1995 and has pursued her goal of making her company the country’s leading producer of pharmaceuticals through the introduction of state-of-the-art technology and improved productivity.
Zhebrovska is no stranger to politics. Her brother, Pavlo, is a lawmaker.
Over the years she has lobbied lawmakers to enact legislation to simplify the registration of generic drugs.
She is credited with convincing former President Viktor Yushchenko to veto legislation imposing price controls on drugs during the 2009 flu epidemic.
The Kyiv Post is hosting comments to foster lively public debate through the Disqus system. Criticism is fine, but stick to the issues. Comments that include profanity or personal attacks will be removed from the site. The Kyiv Post will ban flagrant violators. If you think that a comment or commentator should be banned, please flag the offending material.
Web links to Kyiv Post material are allowed provided that they contain a URL hyperlink to the
www.kyivpost.com material and a maximum 500-character extract of the story. Otherwise, all materials
contained on this site are protected by copyright law and may not be reproduced without the prior
written permission of Public Media at email@example.com
All information of the Interfax-Ukraine news agency placed on this web site is designed for internal
use only. Its reproduction or distribution in any form is prohibited without a written permission of